Blog
Call for more minority groups in clinical studies
At the University of South Florida, researchers have been looking into the genetics makeups of different individuals. They believe that people tend to see one and another as one ethnicity, where in reality people come from all different backgrounds. However, at USF...
Pearl Pathways’ Gretchen Bowker presenting: Indiana Regenerative Medicine Symposium – May 19-20, 2015
Pearl Pathways is a proud sponsor of the upcoming Indiana Regenerative Medicine Symposium entitled “Regulatory Pathways for Regenerative Medicine: Cell and Biological Therapeutics”. This two day event will include four sessions on Day 1 and an opportunity to register...
New smartphone apps helping patients participate in clinical trials
In March, Apple Inc. introduced ResearchKit, a platform where its users can track personal health data and participate in health studies using their smartphone. Some of the apps include mPower used for Parkinson’s disease, My Heart Counts for cardiovascular disease,...
FDA will release draft guidance on accepting clinical data performed outside the United States for medical devices
Set to release Tuesday, April 28, FDA plans to issue a draft guidance document regarding its current policy of accepting clinical trial data performed outside the United States in support of medical device premarket submissions. To be clear, this document is not...
Diana Caldwell, President and CEO of Pearl Pathways, named Indiana’s Outstanding Achiever on behalf of CEED
Pearl Pathways is excited to announce that its President and CEO, Diana Caldwell, has been honored as the Center for Empowerment & Economic Development’s (CEED) Indiana Outstanding Achiever this year. This award is granted by CEED to individuals or organizations...